Welcome to LookChem.com Sign In|Join Free

CAS

  • or

80028-44-0

Post Buying Request

80028-44-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

80028-44-0 Usage

Uses

Ethyl pyrrolidine-3-carboxylate, HCl

Check Digit Verification of cas no

The CAS Registry Mumber 80028-44-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,0,2 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 80028-44:
(7*8)+(6*0)+(5*0)+(4*2)+(3*8)+(2*4)+(1*4)=100
100 % 10 = 0
So 80028-44-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H13NO2.ClH/c1-2-10-7(9)6-3-4-8-5-6;/h6,8H,2-5H2,1H3;1H

80028-44-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H57113)  DL-beta-Proline ethyl ester hydrochloride, 97%   

  • 80028-44-0

  • 250mg

  • 239.0CNY

  • Detail
  • Alfa Aesar

  • (H57113)  DL-beta-Proline ethyl ester hydrochloride, 97%   

  • 80028-44-0

  • 1g

  • 764.0CNY

  • Detail

80028-44-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl pyrrolidine-3-carboxylate,hydrochloride

1.2 Other means of identification

Product number -
Other names 3-pyrrolidinecarboxylic acid ethyl ester hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:80028-44-0 SDS

80028-44-0Relevant articles and documents

JAK INHIBITOR

-

, (2017/12/15)

The present invention discloses a series of JAK inhibitors, and particularly discloses a compound of formula (I) or a pharmaceutically acceptable salt thereof and the use thereof in preparation of drugs for treating diseases related to JAK.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 80028-44-0